Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population

Journal of Neuro-Oncology

Volumn 102, Issue 3, 2011, Pages 347-352

  Malik, Nitin ^a   Kumar, Raj ^a   Prasad, Kashi N ^a   Kawal, Priyanka ^a   Srivastava, Arun ^a   Mahapatra, Ashok K ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Glioblastoma multiforme (GBM); Glioma; Matrix metalloproteinase 1; Polymorphism

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; INDIAN; MALE; MATRIX METALLOPROTEINASE 1 GENE; ONCOGENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; HUMANS; INDIA; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79958220790     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0337-z     Document Type: Article

References (52)

1. CBTRUS (2009) Statistical report: primary brain tumors in the United States, 2004-2005
2. Phatak P, Selvi SK, Divya T, Hegde AS, Hegde S, Somasundaram K (2002) Alterations in tumour suppressor gene p53 in human gliomas from Indian patients. J Biosci 27:673-678 (Pubitemid 36091301)
3. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361:323-331 (Pubitemid 36126198)
4. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15:535-541 (Pubitemid 27190028)
5. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174 (Pubitemid 37328786)
6. Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113-185 (Pubitemid 46911962)
7. Murphy G, Knauper V (1997) Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 15:511-518
8. McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149-156 (Pubitemid 30171365)
9. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer 49:666-672
10. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst (Bethesda) 89:1260-1270
11. Murray G, Duncan ME, O'Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinases-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461-462 (Pubitemid 26191919)
12. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, Fothergill JE (1998) Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. Gut 35:599-603
13. Woo M, Park K, Nam J, Kim JC (2007) Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22:1064-1070 (Pubitemid 47019841)
14. Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V (2008) A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int 101:503-507 (Pubitemid 351160936)
15. Shimizu Y, Kondo S, Shirai A, Furukawa M, Yoshizaki T (2008) A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35:381-389
16. Nishizawa R, Nagata M, Noman AA, Kitamura N, Fujita H, Hoshina H, Kubota T, Itagaki M, Shingaki S, Ohnishi M, Kurita H, Katsura K, Saito C, Yoshie H, Takagi R (2007) The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer 7:187
17. Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Couchane L (2007) Matrix metalloproteinase-1 (-1607) 1G/ 2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 384:57-63 (Pubitemid 47247410)
18. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P (2005) Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res 11:594-599 (Pubitemid 40116884)
19. Cao ZG, Li CZ (2006) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42:32-38
20. Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R (2003) A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200:49-55 (Pubitemid 37222358)
21. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225-4227 (Pubitemid 29418732)
22. Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC (2006) Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis 27:1024-1029
23. McCready J, Broaddus WC, Sykes V, Fillmore HL (2005) Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma. Int J Cancer 117:781-785 (Pubitemid 41598829)
24. Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, Li Y, Xie H, Jiao B, Zhang J (2007) Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol 85:65-73 (Pubitemid 47422657)
25. Fillmore HL, Van Meter T, Broaddus WC (2001) Membrane type metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neuro-Oncol 53:187-202 (Pubitemid 33034691)
26. Van Meter T, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neuro-Oncol 53:213-235 (Pubitemid 33034693)
27. Rao J, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta L, Sawaya R (1994) Role of plasminogen activator and of 92- Kda type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 18: 129-138 (Pubitemid 24216048)
28. Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, Pilkington GJ (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immuno-histochemistry and zymography in human primary brain tumors. International J Oncol 13:153-157
29. Rutka JT, Matsuzawa K, Hubbard SL, Fukuyama K, Becker L, Stetler-Stevenson WG, Edwards D, Dirks PB (1995) Expression of TIMP-1, TIMP-2, 72-and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with invasiveness. Int J Oncol 6:877-884
30. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao J (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35-42 (Pubitemid 26009753)
31. Rao J (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501
32. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix Metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 52:255-264 (Pubitemid 34587810)
33. Binder D, Berger M (2002) Proteases and the biology of glioma invasion. J Neuro-Oncol 56:149-158 (Pubitemid 34272306)
34. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298-307
35. Nakagawa T, Kubota T, Masanori Kabuto, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metalloo-proteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69-77 (Pubitemid 24195510)
36. Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH (2008) Expression of matrix metalloproteinases MMP1, MMP11 and MMP19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40-49
37. Miller SA, Dykes DD, Polesky HFA (1998) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
38. Zhu Y, Spitz M, Lei L, Mills G, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825-7829 (Pubitemid 33049371)
39. Brinckerhoff CE, Rutter JL, Benbow U (2000) Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6:4823-4830 (Pubitemid 32110426)
40. Sternlicht M, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516 (Pubitemid 33096184)
41. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321-5325 (Pubitemid 28551108)
42. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW (2004) Correlation between functional genotypes in the matrix metalloproteinases- 1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 33:323-326
43. Wenham R, Brian Calingarty, Ali S, McClean K, Whitaker R, Bentley R, Lancaster J, Schildkraut J, Marks J, Berchuck A (2003) Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J Soc Gynecol Investig 10:381-387 (Pubitemid 37102848)
44. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoka Y (2003) A Single Nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 106:372-374 (Pubitemid 36870398)
45. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, Kudo R (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612-615 (Pubitemid 30453788)
46. Pirhan D, Atilla G, Emingil G, Sorsa T, Tervahartiala T, Berdeli A (2008) Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J Clin Periodontol 35:862-870
47. Flex A, Gaetani E, Angelini F, Sabusco A, Chilla C, Straface G, Biscetti F, Pola P, Castellot JJ Jr, Pola R (2007) Proinflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Int Med 262:124-130 (Pubitemid 47000627)
48. Song YQ, Ho DW, Karppinen J, Kao PY, Fan BJ, Luk KD, Yip SP, Leong JC, Cheah KS, Sham P, Chan D, Cheung KM (2008) Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese. BMC Med Genet 9:38
49. Kuo HP, Wang YM, Wang CH, He CC, Lin SM, Lin HC, Liu CY, Huang KH, Hsieh LL, Huang CD (2008) Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis 88:262-267
50. Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209-214 (Pubitemid 39177623)
51. Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB (2008) Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102:814-819
52. Ju W, Kim JW, Park NH, Song YS, Kim SC, Kang SB, Lee HP (2007) Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J Obstet Gynaecol Res 33:155-160 (Pubitemid 46376409)